Net profit of Caplin Point Laboratories rose 18.57% to Rs 138.96 crore in the quarter ended December 2024 as against Rs 117.20 crore during the previous quarter ended December 2023. Sales rose 13.19% to Rs 492.96 crore in the quarter ended December 2024 as against Rs 435.50 crore during the previous quarter ended December 2023.
Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
Sales | 492.96 | 435.50 | 13 |
OPM % | 32.92 | 32.67 | - |
PBDT | 193.46 | 159.31 | 21 |
PBT | 177.26 | 145.41 | 22 |
NP | 138.96 | 117.20 | 19 |